K2M has expanded its Vesuvius osteobiologic systems range with the launch of its Versuvius DBM putty—the range already includes demineralised fibres and a demineralised sponge.
According to company press release, the products in the Vesuvius range have been treated with a patented Allowash XG sterilisation process and PAD demineralisation technology to protect bone morphogenic proteins (BMPs) while ensuring optimal osteoinductive potential.
The new DBM putty incorporates proprietary bone-fibre technology and a glycerol carrier to provide an enlarged surface area to facilitate attachment, migration, and distribution of cells within the graft material.
Paul Savas, K2M’s medical director for Tissue Products and orthopaedic surgeon in Williamsburg, Virginia, said: “K2M’s launch of Vesuvius DBM putty is an important expansion of their biologics portfolio. DBM putty is a commonly used osteobiologics solution for spinal fusions, and this offering incorporates a unique carrier for handling characteristics.”
“The launch of this new addition to the Vesuvius product family demonstrates K2M’s continued focus on growing our presence in the biologics market,” stated Eric Major, K2M’s president and chief executive officer
